1. Dual Functional MicroRNA-186-5p Targets both FGF2 and RelA to Suppress Tumorigenesis of Glioblastoma Multiforme
   Fachen Wang et al, 2017, Cell Mol Neurobiol CrossRef
2. Automated detection of ncRNAs in the draft genome sequence of a colonial tunicate: the carpet sea squirt Didemnum vexillum
   Cristian A. Velandia-Huerto et al, 2016, BMC Genomics CrossRef
3. New Insights into the Epigenetics of Hepatocellular Carcinoma
   Braira Wahid et al, 2017, BioMed Research International CrossRef
4. Regulation of FSH expression by differentially expressed miR-186-5p in rat anterior adenohypophyseal cells
   Dong-Xu Han et al, 2018, PLoS ONE CrossRef
5. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells
   Dominique Z. Jones et al, 2018, BMC Cancer CrossRef
6. FXR Inhibits Endoplasmic Reticulum Stress-Induced NLRP3 Inflammasome in Hepatocytes and Ameliorates Liver Injury
   Chang Yeob Han et al, 2018, Cell Reports CrossRef
7. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway
   Shao-Ying Li et al, 2018, Cancer Gene Ther CrossRef
8. miR‐186 inhibits proliferation, migration, and epithelial‐mesenchymal transition in breast cancer cells by targeting Twist1
   Wen‐juan Sun et al, 2018, J Cell Biochem CrossRef
9. MicroRNA-186 is associated with hypoxia-inducible factor-1α expression in chronic obstructive pulmonary disease
   Li Lin et al, 2018, Mol Genet Genomic Med CrossRef
10. The Role of MicroRNAs in Hepatoblastoma Tumors
    Ion Cristóbal et al, 2019, Cancers CrossRef
11. Crosstalk between Hippo signalling and miRNAs in tumour progression
    Nianshuang Li et al, 2017, FEBS J CrossRef
12. Functions and mechanisms of miR-186 in human cancer
    Zhen Wang et al, 2019, Biomedicine & Pharmacotherapy CrossRef
13. null
    K.T. Bogen, 2016 CrossRef
14. Search for useful biomarkers in hepatocellular carcinoma, tumor factors and background liver factors
    Dai Shimizu et al, 2017 CrossRef
15. The Hippo pathway in hepatocellular carcinoma: Non-coding RNAs in action
    Xuan Shi et al, 2017, Cancer Letters CrossRef
16. MicroRNA-187 inhibits tumor growth and metastasis via targeting of IGF-1R in hepatocellular carcinoma
    Xinqiang Han et al, 2017 CrossRef
17. MicroRNA-363-3p is downregulated in hepatocellular carcinoma and inhibits tumorigenesis by directly targeting specificity protein 1
    Jie Ying et al, 2017 CrossRef
18. Long non-coding RNA PVT1 serves as a competing endogenous RNA for miR-186-5p to promote the tumorigenesis and metastasis of hepatocellular carcinoma.
    Tian Lan et al, 2017, Tumour Biol CrossRef
19. The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186
    Yuan Wang et al, 2017, J. Biol. Chem. CrossRef
20. MicroRNA-186 targets IGF-1R and exerts tumor-suppressing functions in glioma
    Jian Jiang et al, 2017 CrossRef
21. Quercetin and naringenin abate diethylnitrosamine/acetylaminofluorene-induced hepatocarcinogenesis in Wistar rats: the roles of oxidative stress, inflammation and cell apoptosis
    Osama M. Ahmed et al, 2019, Drug and Chemical Toxicology CrossRef
22. Long non-coding RNA KCNQ1OT1 regulates cell proliferation, apoptosis and chemo-sensitivity through modulating the miR-186-5p/NCAM1 axis in acute myeloid leukemia cells
    Jing Dai et al, 2019, RSC Adv. CrossRef
23. Altered Expression of MiR-186-5p and its Target Genes after Spinal Cord Ischemia–Reperfusion Injury in Rats
    Fengshou Chen et al, 2019, Neuroscience Letters CrossRef
24. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
    Xichun Cui et al, 2020, Cell Prolif CrossRef
25. The Dual Role of miR-186 in Cancers: Oncomir Battling With Tumor Suppressor miRNA
    Ying Xiang et al, 2020, Front. Oncol. CrossRef
26. Suppression of miR-16 promotes tumor growth and metastasis through reversely regulating YAP1 in human cholangiocarcinoma
    Sheng Han et al, 2017, Oncotarget CrossRef
27. miR-186 reverses cisplatin resistance and inhibits the�formation of the glioblastoma-initiating cell�phenotype by degrading Yin Yang 1 in glioblastoma
    Jian Li et al, 2018, Int J Mol Med CrossRef
28. Dexmedetomidine Provides Protection Against Hippocampal Neuron Apoptosis and Cognitive Impairment in Mice with Alzheimer’s Disease by Mediating the miR-129/YAP1/JAG1 Axis
    Weiying Sun et al, 2020, Mol Neurobiol CrossRef
29. Regulatory role of microRNAs in cancer through Hippo signaling pathway
    Reza Vaezi Astamal et al, 2020, Pathology - Research and Practice CrossRef
30. Isorhapontigenin protects against doxorubicin-induced cardiotoxicity via increasing YAP1 expression
    Panxia Wang et al, 2020, Acta Pharmaceutica Sinica B CrossRef
31. A MicroRNA Cluster in the DLK1-DIO3 Imprinted Region on Chromosome 14q32.2 Is Dysregulated in Metastatic Hepatoblastomas
    Shohei Honda et al, 2020, Front. Oncol. CrossRef
32. Regulation of Hippo signaling pathway in cancer: A MicroRNA perspective
    Priyanka Samji et al, 2020, Cellular Signalling CrossRef
33. Natural Killer–Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms
    Paolo Neviani et al, 2019, Cancer Res CrossRef
34. MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer
    Na-Hyun Lee et al, 2021, Biomedicines CrossRef
35. COL4A1, negatively regulated by XPD and miR-29a-3p, promotes cell proliferation, migration, invasion and epithelial-mesenchymal transition in liver cancer cells.
    H Zhang et al, 2021, Clin Transl Oncol CrossRef
36. Upregulated microRNA let-7a accelerates apoptosis and inhibits proliferation in uterine junctional zone smooth muscle cells in adenomyosis under conditions of a normal activated hippo-YAP1 axis
    Jun-Hua Huang et al, 2021, Reprod Biol Endocrinol CrossRef
37. MiR-186-3p attenuates tumorigenesis of cervical cancer by targeting IGF1
    Xiurong Lu et al, 2021, World J Surg Onc CrossRef
38. microRNAs: Key players in virus‐associated hepatocellular carcinoma
    Javid Sadri Nahand et al, 2019, J Cell Physiol CrossRef
39. miR-186-3p attenuates the tumorigenesis of cervical cancer via targeting insulin-like growth factor 1 to suppress PI3K-Akt signaling pathway
    Xiurong Lu et al, 2021, Bioengineered CrossRef
40. The Role of MicroRNAs in Therapeutic Resistance of Malignant Primary Brain Tumors
    Ilgiz Gareev et al, 2021, Front. Cell Dev. Biol. CrossRef
41. Thyme Oil and Thymol Counter Doxorubicin-Induced Hepatotoxicity via Modulation of Inflammation, Apoptosis, and Oxidative Stress
    Osama M. Ahmed et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
42. Crucial Roles of miR-625 in Human Cancer
    Menggang Zhang et al, 2022, Front. Med. CrossRef
43. miRNAs and the Hippo pathway in cancer: Exploring the therapeutic potential (Review)
    Taruna Arora et al, 2022, Oncol Rep CrossRef
44. Cross-regulation between microRNAs and key proteins of signaling pathways in hepatocellular carcinoma
    Haihong Hu et al, 2022, Expert Review of Gastroenterology & Hepatology CrossRef
45. Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway
    Geofrey Mahiki Mranda et al, 2022, Front. Oncol. CrossRef
46. Regulation of IGF2BP1 by miR-186 and its impact on downstream lncRNAs H19, FOXD2-AS1, and SNHG3 in HCC
    Danira Ashraf Habashy et al, 2022, Life Sciences CrossRef
47. Regulation of IGF2BP1 by miR-186 and its Impact on Downstream lncRNAs H19, FOXD2-AS1, and SNHG3 in HCC
    Danira Ashraf Habashy et al, 2022, SSRN Journal CrossRef